Origins of Covid

Status
Not open for further replies.
More Lancet mea culpa:

BMJ Oct 2021: Covid-19: Lancet investigation into origin of pandemic shuts down over bias risk
The work of a task force commissioned by the Lancet into the origins of covid-19 has folded after concerns about the conflicts of interest of one its members and his ties through a non-profit organisation to the Wuhan Institute of Virology.

Task force chair Jeffrey Sachs, economics professor at Columbia University in New York, told the Wall Street Journal that he had shut down the scientist led investigation into how the covid-19 pandemic started because of concerns about its links to the EcoHealth Alliance, a non-profit organisation run by task force member Peter Daszak.1 ...

The decision came as evidence continued to accumulate that Daszak had not always been forthright about his research and his financial ties to the Wuhan Institute of Virology. Daszak now faces increased scrutiny from scientists, the media, and members of US Congress. ...

Daszak’s story began falling apart last November when the non-profit group US Right to Know published emails gathered through a freedom of information request that showed he had orchestrated the Lancet statement without disclosing that he was funding Shi Zhengli through grants from the National Institutes of Health (NIH). ...

That same month the Lancet posted an addendum to the February 2020 statement,6 /b]which had previously read, “We declare no competing interests.” The half page addendum discusses EcoHealth Alliance’s funding of researchers in China and studies involving recombinant bat viruses. Daszak also resigned that month from the Lancet task force.


But wait, there's more:
further information emerged questioning the veracity of several other statements made by Daszak. After suing the NIH to gain access to Daszak’s grants, the US media organisation the Intercept released details of several of Daszak’s NIH grants and grant applications, including one that seemed to involve gain-of-function research by creating chimeric SARS viruses. ...

a week after the Intercept’s story a group of online investigators called DRASTIC (Decentralized Radical Autonomous Search Team Investigating Covid-19) published leaked documents that included a grant application that Daszak had submitted to the US Department of Defense in 2018. In that document Daszak proposed creating chimeric SARS viruses. The department declined to fund Daszak’s grant, adding that if it were funded in the future the chimeric research would require a risk mitigation plan for gain-of-function research.
Guess that was a grant proposal for GoF research after all.

That the NIH grant was denied doesn't preclude the WIV obtaining funding through the Chinese government or some other of Daszak's fungible donations.
 
And more re the media being conned:

BMJ: The covid-19 lab leak hypothesis: did the media fall victim to a misinformation campaign?

The evidence says, why yes, yes they did.
The theory that SARS-CoV-2 may have originated in a lab was considered a debunked conspiracy theory, but some experts are revisiting it amid calls for a new, more thorough investigation. Paul Thacker explains the dramatic U turn and the role of contemporary science journalism ...

Scientists and reporters contacted by The BMJ say that objective consideration of covid-19’s origins went awry early in the pandemic, as researchers who were funded to study viruses with pandemic potential launched a campaign labelling the lab leak hypothesis as a “conspiracy theory.”


This should piss people off in this thread debate, not encourage even more doubling down calling the lab leak hypotheses a CT.
 
Some obvious ignorance quoted from the Richard Muller and Steven Quay op-ed in the WSJ.
That "extensive data set from late 2019—more than 9,000 hospital samples" just shows there were no COVID-19 infections in the samples in late 2019 in Hubei and Shaanxi provinces. That is powerful evidence that COVID-19 originated after that "late 2019" probably from animals or less likely from a lab leak.. This is really simple:
  • A spillover event after the samples were collected predicts no infections.
  • A spillover event before the samples were collected predicts infections.
  • A lab leak after the samples were collected predicts no infections.
  • A lab leak before the samples were collected predicts infections.
Wiki: Richard A Muller shows that he is a 77 year old, retired physicist. Anyone writing "This is powerful evidence favoring the lab-leak theory." is ignorant of or ignoring basic biology. No matter what the origin of COVID-19 is, the virus or antibodies would be in the samples only if that origin was before the samples were taken. Both origins are supported by the evidence. What the evidence does show is that COVID-19 originated after late 2019.

People with sense will discount an obviously ignorant opinion piece in a financial journal by a retired physicist and a physician who publishes with the DRASTIC clowns (Gilles Demaneuf and DRASTIC Team)
 
Last edited:
Here's the paragraph from the SciAm interview:
It is clear you are are still unable to see what are Shi's words in that quote and which are the reporter's.
“The mine shaft stunk like hell,” says Shi, who, like her colleagues, went in wearing a protective mask and clothing. “Bat guano, covered in fungus, littered the cave.” Although the fungus turned out to be the pathogen that had sickened the miners, she says it would have been only a matter of time before they caught the coronaviruses if the mine had not been promptly shut.
Shi's actual words are in quotes. The reporters version of what else Shi said in their words are not. It is possible that "Although the fungus turned out to be the pathogen that had sickened the miners" are purely from the reporter. In any case
  • The fungal infection claim is not an actual quote from Shi.
  • If Shi said that the miners became ill from fungal infection, Shi was telling the truth.
    There is no evidence that they had a viral infection. Their symptoms did not differentiate between fungal and viral pneumonia. Shi and her colleagues ruled out 3 viral infections.
 
Funny how the Lancet has changed its tune to embrace a CT. :rolleyes:

Voice of Healthcare, Sept 2021: Covid origins probe: The Lancet does U-turn over lab leak theory


The Daszak letter said:
Like I said ...

But independent scientists struck back with a letter of their own, one that wasn't mired in deceit:




Lancet Sept 17, 2021: An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2


There is little to no evidence for a spillover:The logical fallacies are described in the letter.

The letter goes on to describe all the evidence and possible mechanisms for a lab origin. In the end they state that there is no compelling evidence to choose between either origin hypotheses.

More Lancet mea culpa:

BMJ Oct 2021: Covid-19: Lancet investigation into origin of pandemic shuts down over bias risk

But wait, there's more:
Guess that was a grant proposal for GoF research after all.

That the NIH grant was denied doesn't preclude the WIV obtaining funding through the Chinese government or some other of Daszak's fungible donations.

And more re the media being conned:

BMJ: The covid-19 lab leak hypothesis: did the media fall victim to a misinformation campaign?

The evidence says, why yes, yes they did.



This should piss people off in this thread debate, not encourage even more doubling down calling the lab leak hypotheses a CT.

This is just heavy editorializing with your claims that the Lancet etc... are doing mea culpas, etc...

What you are talking about is just that they published letters in their letter pages from Lab Leak proponents and going, "HA ha!" But of course, it merely undercuts your claim that none dare speak out because of the influence of the dastardly Peter Darth Vader Daszak.

In fact, you then say that he had GoF funding not authorized so how it boosts your claim that everyone says spillover to get funding is some weird pretzel logic that I cannot untangle.
 
Has anyone seen any quote "claiming there were no in vitro CoV cultures at the WIV"

Let's list some of the more blatant lies trying to mislead opinion on the lab leak hypothesis:
A repeated fantasy of blatant lies.
  • There may be outdated or less knowledgeable sourced still claiming that the seafood market was the connected to the first cases. This does not mislead
    about the lab leak hypostasis. WUIV people would eat seafood! If that market were a source.
  • What looks like a "another wet market associated with the first case " fantasy.
  • Shi's claim the Yunnan miners died of a fungal infection is valid.
    Their symptoms were compatible with fungal pneumonia and viral pneumonia. Blood samples were tested and 3 viruses including a bat virus or antibodies were not found. The probable cause of death is fungal infection.
    Then there is your "incredibly rare" infection rate below :eye-poppi!
    If spillover events are "incredibly rare" then how did 6 miners get infected?
    Were there hundreds of miners in the cave working for a year?
    1 September 2021 onward: Repeating fantasies does not make Shi into a liar.
  • A "Daszak's dishonest manipulation using the Lancet letter he wrote" lie. It was an open letter to the Lancet containing the authors option. An open letter to a journal is statements that they hope other people would agree with
    Unfortunate language but that is not dishonest.
    Daszak should have made his association with the WIV clear which was fixed later.
  • No evidence of "Daszak's claim there were lots of spillover events involving coronaviruses and bats".
    We have evidence of 7 such spillover events in the last 50 years (Bat-borne virus diversity, spillover and emergence). Extend this to say 100,000 years with adjustments for population and "lots" would be justified.
    23 September 2021: Daszak's preprint and paper do not disagree.
    Daszak was a coauthor on a preprint that modeled interactions with bats and came to a potential number of ~400,000 people infected a year.
    Daszak was a coauthor on a paper looking at CoV antibodies in people living near the Yunnan caves where the bats live found found a number that is compatible with Daszak's preprint (150,000 infections per year).
    Highlighting of "incredibly rare" is a lie when that is not what the paper says. The paper just says "The low seroprevalence observed in this study suggests that bat coronavirus spillover is a rare event."
Has anyone seen any any quote "claiming there were no in vitro CoV cultures at the WIV" from Shi?
Sounds like just a unfounded assertion from Skeptic Ginger or maybe rubbish from DRASTIC. It is well known that the WIV isolated and grew 3 bat CoV. Shi would know that!
 
Last edited:
This is just heavy editorializing with your claims that the Lancet etc... are doing mea culpas, etc...

What you are talking about is just that they published letters in their letter pages from Lab Leak proponents and going, "HA ha!" But of course, it merely undercuts your claim that none dare speak out because of the influence of the dastardly Peter Darth Vader Daszak.

In fact, you then say that he had GoF funding not authorized so how it boosts your claim that everyone says spillover to get funding is some weird pretzel logic that I cannot untangle.
This post makes no sense in relation to the evidence posted. You are just ignoring anything/everything that doesn't confirm your bias, that or you have no desire to actually be serious.


It's unfortunate you are not willing to/interested in actually discussing the evidence.
 
Last edited:
This post makes no sense in relation to the evidence posted. You are just ignoring anything/everything that doesn't confirm your bias, that or you have no desire to actually be serious.


It's unfortunate you are not willing to/interested in actually discussing the evidence.

I'm not really sure what "evidence" you want me to discuss. Most of what you posted is long on insinuation and speculation and short on evidence.
 
It's not like we detect new variant and say 'hey look, this is new'. The virus changes in almost every transmission. We collect viruses over time from all over the world and every sample is different. We can compare the changes and build tree of what's closest to each other, which comes from which.

Ok I see how the comparison is done when changes occur.
What I'm more interested in finding out is how the virus sample itself was isolated and tested after discovery/or given to be tested to provide the proof and therefore documented.
I was looking through the CDC site to possibly find this, but it seems as though the CDC had no actual virus..

https://www.fda.gov/media/134922/downloadhttps://www.fda.gov/media/134922/download
On page 40 of Performance Characteristics it reads as follows:
Since no quantified virus isolates of the 2019-nCoV were available for CDC use at the time the test was developed and this study conducted, assays designed for detection of the 2019-nCoV RNA were tested with
characterized stocks of in vitro transcribed full length RNA (N gene; GenBank accession: MN908947.2) of
known titer (RNA copies/µL) spiked into a diluent consisting of a suspension of human A549 cells and
viral transport medium (VTM) to mimic clinical specimen.

The hilited section above indicates they had no virus isolates when the test was developed and when the study was conducted.
 
Last edited:
Ok I see how the comparison is done when changes occur.
What I'm more interested in finding out is how the virus sample itself was isolated and tested after discovery/or given to be tested to provide the proof and therefore documented.
I was looking through the CDC site to possibly find this, but it seems as though the CDC had no actual virus..

https://www.fda.gov/media/134922/downloadhttps://www.fda.gov/media/134922/download
On page 40 of Performance Characteristics it reads as follows:
Since no quantified virus isolates of the 2019-nCoV were available for CDC use at the time the test was developed and this study conducted, assays designed for detection of the 2019-nCoV RNA were tested with
characterized stocks of in vitro transcribed full length RNA (N gene; GenBank accession: MN908947.2) of
known titer (RNA copies/µL) spiked into a diluent consisting of a suspension of human A549 cells and
viral transport medium (VTM) to mimic clinical specimen.

The hilited section above indicates they had no virus isolates when the test was developed and when the study was conducted.
Fortunately, the virus was isolated from the first cases and the sequence was determined and deposited in the database. From that sequence, it is possible to design primers and probes for the RT-PCR assay and the assay performance was checked using cell culture-derived RNA (see above). Again the full-length RNA was produced from the published sequence. The assay can be developed using synthetically produced RNA/DNA without the need of the virus but you need the sequence.
 
Last edited:
Fortunately, the virus was isolated from the first cases and the sequence was determined and deposited in the database. From that sequence, it is possible to design primers and probes for the RT-PCR assay and the assay performance was checked using cell culture-derived RNA (see above). Again the full-length RNA was produced from the published sequence. The assay can be developed using synthetically produced RNA/DNA without the need of the virus but you need the sequence.

I have been watching for more corroboration or challenging the results of Quay et al's analysis.

And I've been looking to see if anything in the Bangladesh specimens Daszak or EcoHealth collected has any unique markers also found in the Nipah virus sequences of the COVID 19 analyses.

Isolation and Full-Genome Characterization of Nipah Viruses from Bats, Bangladesh
Affiliations ... EcoHealth Alliance, New York, New York, USA (Ariful Islam, P. Daszak, J.H. Epstein); ...

We report isolation of NiVs from P. medius bats in Bangladesh. We performed full-genome characterization of these viruses by using enrichment-based next-generation sequencing (NGS)....

During January 2011–April 2014, we collected 2,749 bat samples from various ongoing projects in the region. We collected samples nondestructively from individual bats as described (7) and collected environmental urine samples from underneath roosts by using polyethylene sheets. ...

Samples were tested at the CSIRO Australian Animal Health Laboratory under BioSafety Level 4 containment. ...

For virus isolation from PCR-positive samples, we prepared Vero cells in 96-well plates in Eagle minimum essential medium (EMEM) ... Virus stocks were amplified in Vero cells, and supernatants were harvested ...

Full-length genome sequences were obtained from 10 bat NiV isolates. We constructed a phylogenetic tree (Figure 2) that showed all bat isolates had nearly identical genome sequences; there was 99.9% conservation among all 10 genomes characterized (Table). The virus isolated in Sylhet during January 2013 was nearly identical to all other isolates obtained in 2013 in Raipur, which is ≈350 km from Sylhet, suggesting that NiV homogeneity might be supported by bat movements connecting disparate bat colonies (10).
Results were recorded in GenBank.



The thing about using the gene sequences on file is it rules out Quay et al finding the genetic sequences upon re-examining the specimens directly.

Right now the issues are:

Did they really find Nipah sequences in the data? That should be easy to confirm or refute. And the finding of contamination is significant. Were it only the odd things like grass pollen or whatever Quay said in the interview, one could explain that as probable contamination in collecting and transporting the specimens. But where Nipah virus contamination occurred if it did, had to have been within the WIV walls, but not necessarily in the BSL4 lab.

I am reminded of one of the first hospital searches for COVID contamination and it was found everywhere from the floors to the supply rooms. IOW anywhere healthcare workers tracked it on their shoes and where contaminated air flowed (few if any of these viral particles proved to be complete or infectious). That's completely different of course because they were dealing with patients who were shedding a large amount of virus. But it does suggest an improper ventilation system in the WIV labs could have spread contamination all over the labs including to the COVID specimens. And that need not have been viable Nipah virus so one would not see detection of the problem via an outbreak.



One question needed to be asked is where was the COVID genome sequencing done?

Lancet
The nine samples analyzed were from the first recognized patients from the Huanan Seafood market cluster.
Five of the patients (WH19001, WH19002, WH19004, WH19008, and YS8011) had samples collected by the Chinese Center for Disease Control and Prevention (CDC) ... Four of the patients (WH01, WH02, WH03, and WH04) had samples collected by BGI (Beijing, China) ... All collected samples were sent to BGI for sequencing.
BGI is a private company with offices in China and elsewhere. They must have their own lab(s) in Beijing so there is not necessarily a connection here to the WIV though there is one to the CCDC.

It shouldn't be that hard to compare the sequences Quay et al looked at with this cluster. According to the Quay report: Nipah virus vector sequences in COVID-19 patient samples sequenced by the Wuhan Institute of Virology
We report the detection of Nipah virus in an infectious clone format, a BSL4-level pathogen and CDC-designated Bioterrorism Agent, in raw RNA-Seq sequencing reads deposited by the Wuhan Institute of Virology (WIV) produced from five December 2019 patients infected with SARS-CoV-2.
Not sure what to make of "in an infectious clone format".

At a minimum one should be able to compare those 5 sequences with either the other 4 or 9 sequences in the Lancet depending on which 5 specimens Quay is talking about.

And while the Lancet article says BGI Beijing, this is from the company's website:
The company is headquartered in Shenzhen, China. It has branches and medical laboratories in major domestic cities such as Beijing, Tianjin, Wuhan, Shanghai, Guangzhou, and Hong Kong. ....
I'll have to keep looking.



Interesting finding:
The eight complete genomes were nearly identical across the whole genome, with sequence identity above 99·98%, indicative of a very recent emergence into the human population (figure 1A). The largest nucleotide difference was four mutations. Notably, the sequence identity between the two virus genomes from the same patient (WH19001, from bronchoalveolar lavage fluid, and WH19005, from cell culture) was more than 99·99%, with 100% identity at the amino acid level. In addition, the partial genomes from samples WH02 and WH19002 also had nearly 100% identity to the complete genomes across the aligned gene regions.
IIRC these were all from lineage B. Note there are references to lineage A, B and C which are not the same as the A and B lineages noted in the first COVID specimens. It gets very confusing when these same labels differ in different articles.



Other interesting comments:
First, the outbreak was first reported in late December, 2019, when most bat species in Wuhan are hibernating. Second, no bats were sold or found at the Huanan seafood market, whereas various non-aquatic animals (including mammals) were available for purchase.
They suggest an intermediate species which we know has not been found.

And one patient had not visited the market:
Eight of the patients had visited the Huanan seafood market before the onset of illness, and one patient (WH04) did not visit the market but stayed in a hotel near the market between Dec 23 and Dec 27, 2019 (table)



The other question of course is, are the Quay et al conclusions correct that these sequences were evidence of the Nipah virus being adapted in the lab? I expect much more pushback on these conclusions.


Guess I need to go back through these reports: Feb 2021: Vector sequences in early WIV SRA sequencing data of SARS-CoV-2 inform on a potential large-scale security breach at the beginning of the COVID-19 pandemic

Feb 2020: A pneumonia outbreak associated with a new coronavirus of probable bat origin

Maybe could have saved myself some time.

:popcorn1
 
Last edited:
.... I was looking through the CDC site to possibly find this, but it seems as though the CDC had no actual virus..

https://www.fda.gov/media/134922/downloadhttps://www.fda.gov/media/134922/download
On page 40 of Performance Characteristics it reads as follows:
Since no quantified virus isolates of the 2019-nCoV were available for CDC use at the time the test was developed and this study conducted, assays designed for detection of the 2019-nCoV RNA were tested with characterized stocks of in vitro transcribed full length RNA (N gene; GenBank accession: MN908947.2) of known titer (RNA copies/µL) spiked into a diluent consisting of a suspension of human A549 cells and viral transport medium (VTM) to mimic clinical specimen.

The hilited section above indicates they had no virus isolates when the test was developed and when the study was conducted.
That's completely different from the specimens from the first COVID patients so I'm not sure what you are saying.

And remember China has its own CDC. I use the acronym CCDC to designate the Chinese CDC.
 
Last edited:
Well Yuri Deigin and Steven Quay are both pretty active on Twitter and elsewhere. I suppose we could contact them directly to find out more about what they presume happen.

I think it WOULD be interesting if we think that the sequencing was done at a BSL that was inappropriate for Nipah (which is BSL-4) but had some contamination from Nipah.

That said, I truly don’t understand what is being claimed here.
 
One question needed to be asked is where was the COVID genome sequencing done?

Lancet
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding is irrelevant to the question. This was testing done when the outbreak was almost 2 months old. There is no connection to the WIV.
  • BGI having labs in Wuhan does not say that this analysis was done in Wuhan.
  • We know that the virus has "a very recent emergence into the human population", e.g. the first known case is in early December 2019.
  • Patient WH04 reported a fever on Dec 27, 2019.
    It is not a surprise that they had not visited the Huanan seafood market before becoming ill, when COVID-19 is infectious. They "stayed in a hotel near the market between Dec 23 and Dec 27, 2019". That is 4 days of exposure to a carrier who had visited the market. for example, think about where the hotel got its seafood.
 
Last edited:
I have been watching for more corroboration or challenging the results of Quay et al's analysis.
Nipah virus vector sequences in COVID-19 patient samples sequenced by the Wuhan Institute of Virology is a preprint submitted on 19 Sep 2021.
COVID-19 e-print
Important: e-prints posted on arXiv are not peer-reviewed by arXiv; they should not be relied upon without context to guide clinical practice or health-related behavior and should not be reported in news media as established information without consulting multiple experts in the field.
What is bad about this preprint
  • The abstract sounds like previous "COVID-19 was genetically engineered" nonsense with "encapsulated in synthetic vectors".
    Later there is "Here we review the recovery of a partial infectious clone of a Bangladesh strain of Nipah virus".
  • Preprints usually state where they have been submitted, accepted or published. A month and that preprint has not been submitted, accepted or published.
  • Authors with no appropriate affiliation or credentials.
Nipah virus "normally circulates among some fruit bats". Other bats species carrying the virus not unexpected. Shi and 28 colleagues tested for the miner samples for Nipah virus, presumably based on that expectation.
19 October 2021: Shi and 28 colleagues published that miner blood samples were tested (no coronavirus or antibodies)
 
Last edited:
This is interesting and I can't find much in the way of followup. I also looked for viral co-infections with COVID and didn't see anything else mentioning Nipah or viruses in that family.

There was a simultaneous outbreak of the zoonotic Nipah henipavirus inWuhan - 4 out of 5 patients have the virus in Jinyintan Hospital, along withSARS-Cov2, in their metagenome - which seems to have resolved by itself
The metagenome also shows the co-infection with Nipah henipavirus virus in 4 out of 5 patients. The sequences are in SI:Nipah.fa - 167 reads in all.One can almost assemble the full genome (about 18kbps) from it. It seems to have originated fromBangladesh, though I have not done the phylogeny. Most reads are 100% identical, but some are (97% -145/150).

It does look like the 5 early patients who had genome sequencing at the WIV were from the seafood market cluster.

I'm not sure how to reconcile those 5 specimens with 9 noted in the above Lancet citation:
... nine inpatients, eight of whom had visited the Huanan seafood market in Wuhan.

Perhaps the specimens were analyzed at a different time or in a different lab.


From the Quay et al paper:
Here we document the presence of Nipah virus (NiV) sequences, Banglisash strain, interpreted as likely for assembly of a NiV infectious clone, found in raw sequencing reads by the Wuhan Institute of Virology (WIV) from five patients infected with SARS-CoV-2 sampled by the Wuhan Jin Yin-Tan Hospital at the beginning of the COVID-19 outbreak (Zhou et al. 2020). The five patients experienced COVID-19 illness onset between 12/12/2019 and 23/12/2019 and were admitted to intensive care between 20/12/2019 and 29/12/2019 with all BALF (bronchoalveolar lavage fluid) sampling conducted on the 30/12/2019 and the 10/1/2020.


4 of 5 or 5 of 5 also doesn't match up exactly. But they are talking about the same patients and specimens:
These patient samples have been previously reported to contain reads from several other viruses: Influenza A, Spodoptera frugiperda rhabdovirus and Nipah. Previous authors have interpreted the presence of these virus sequences as indicative of co-infections of the patients in question by these pathogens or laboratory contamination. However, our analysis shows that NiV genes are encapsulated in synthetic vectors, which we infer was for assembly of a NiV infectious clone.
There was no corroboration any of the patients had co-infection with Nipah. And it seems like the "lab contamination" hypothesis wasn't pursued but there it is right there in plain sight.

So there were genetic sequences from Nipah and no reason for the sequences to be there. That much corroborates Quay et al.

The interpretation that the Nipah virus segments had signs of being manipulated remains to be corroborated, of course. But why was evidence of Nipah there at all?
:popcorn1
 
Last edited:
This is interesting and I can't find much in the way of followup. I also looked for viral co-infections with COVID and didn't see anything else mentioning Nipah or viruses in that family.

There was a simultaneous outbreak of the zoonotic Nipah henipavirus inWuhan - 4 out of 5 patients have the virus in Jinyintan Hospital, along withSARS-Cov2, in their metagenome - which seems to have resolved by itself


It does look like the 5 early patients who had genome sequencing at the WIV were from the seafood market cluster.

I'm not sure how to reconcile those 5 specimens with 9 noted in the above Lancet citation:
... nine inpatients, eight of whom had visited the Huanan seafood market in Wuhan.

Perhaps the specimens were analyzed at a different time or in a different lab.


From the Quay et al paper:



4 of 5 or 5 of 5 also doesn't match up exactly. But they are talking about the same patients and specimens:

There was no corroboration any of the patients had co-infection with Nipah. And it seems like the "lab contamination" hypothesis wasn't pursued but there it is right there in plain sight.

So there were genetic sequences from Nipah and no reason for the sequences to be there. That much corroborates Quay et al.

The interpretation that the Nipah virus segments had signs of being manipulated remains to be corroborated, of course. But why was evidence of Nipah there at all?
:popcorn1
I'm confused. Is this Nipah virus or Henipahvirus? The two are not necessarily the same. The assay could easily confuse the two.
Sequencing does not need to be done in BSL-4, once the RNA is extracted (within a safety cabinet) it can be handled at BSL-2.
 
That's completely different from the specimens from the first COVID patients so I'm not sure what you are saying.

And remember China has its own CDC. I use the acronym CCDC to designate the Chinese CDC.

What I'm looking for is documentation of the original virus to substantiate it's actual existence proving this virus is exactly what they say it is because there are legal challenges being made recently in courts of law. Challenges that dispute the PCR testing on the one hand that determines some people as testing positive although they are listed "Asymptomatic". Since these people have no symptoms at all, how could it be proven they are actually sick?
Either man-made or mammal, but no actual documentation to prove that it is a "Novel" virus. I have one person who tried to find documentation of the actual virus to prove it exists: This person tried to obtain this very same information by requesting it through the Freedom Of Information Act in his state of Illinois "All records of scientific laboratory tests, analyzing and identifying the COVID-19 delta variant virus from isolate samples extracted from a human being".
The state sent him a letter back 6 weeks later that reads "after conducting a search, the Governors Office has located no records responsive to your request".
 
Last edited:
What I'm looking for is documentation of the original virus to substantiate it's actual existence proving this virus is exactly what they say it is because there are legal challenges being made recently in courts of law. Challenges that dispute the PCR testing on the one hand that determines some people as testing positive although they are listed "Asymptomatic". Since these people have no symptoms at all, how could it be proven they are actually sick?
Either man-made or mammal, but no actual documentation to prove that it is a "Novel" virus. I have one person who tried to find documentation of the actual virus to prove it exists: This person tried to obtain this very same information by requesting it through the Freedom Of Information Act in his state of Illinois "All records of scientific laboratory tests, analyzing and identifying the COVID-19 delta variant virus from isolate samples extracted from a human being".
The state sent him a letter back 6 weeks later that reads "after conducting a search, the Governors Office has located no records responsive to your request".
Original publications
https://www.nature.com/articles/s41586-020-2008-3
https://www.nature.com/articles/s41586-020-2012-7
 
I'm confused. Is this Nipah virus or Henipahvirus? The two are not necessarily the same. The assay could easily confuse the two.
Sequencing does not need to be done in BSL-4, once the RNA is extracted (within a safety cabinet) it can be handled at BSL-2.
Looking it up (because I didn't know), Nipah is also called Nipah henipahvirus even though there is a separate henipahvirus group.

Here are the Wiki pages for each:
Henipavirus is a genus of negative-strand RNA viruses in the family Paramyxoviridae, order Mononegavirales containing five species.[1][2]

Nipah virus, scientific name Nipah henipavirus, is a bat-borne virus that causes Nipah virus infection in humans and other animals, a disease with a high mortality rate.

It would appear Nipah virus is what both Sandeep Chakraborty (the first analysis) and Quay et al are referring to.

I didn't see the details of which lab within the WIV the initial COVID specimens were analyzed in. That short letter is the only mention I found so far.

The hospital the patients were in corroborates which patients the specimens came from. Interesting in that your first link notes 7 specimens:
Samples from seven patients with severe pneumonia (six of whom are sellers or deliverymen from the seafood market), who were admitted to the intensive care unit of Wuhan Jin Yin-Tan Hospital at the beginning of the outbreak, were sent to the laboratory at the Wuhan Institute of Virology (WIV) for the diagnosis of the causative pathogen

The letter notes the same hospital:
Jinyintan hospital

It seems possible the different number of specimens reflect an initial batch followed by subsequent additional specimens being analyzed.


It still appears there was a lot of contamination in at least one of the WIV labs. It wasn't just Nipah that Quay et al identified in the early COVID specimens.


This is from the 2012 search of bat specimens and needs to be sorted out as well. I'll have to go back and look at why they suspected and then ruled out this rat virus when COVID first emerged.
CDC Novel Henipa-like Virus, Mojiang Paramyxovirus, in Rats, China, 2012
To the Editor: The genus Henipavirus (family Paramyxoviridae) contains 3 established species (Hendra virus, Nipah virus, and Cedar virus) and 19 newly identified species, including 1full-length sequenced virus, Bat Paramyxovirus Eidhel/GH-M74a/GHA/2009 (1,2). The zoonotic pathogens Hendra virus and Nipah virus have been associated with lethal neurologic and respiratory diseases in humans, horses, and pigs (3–5). The known natural reservoirs of henipaviruses are fruit bats (1,3); these viruses have not been reported in other wild animals. We report on a novel henipa-like virus, Mojiang paramyxovirus (MojV), in rats (Rattus flavipectus) in China. ...

Half a year later [after the miners became ill], we investigated the presence of novel zoonotic pathogens in natural hosts in this cave. ...

On the basis of the nonredundant protein alignment results, we identified 38 sequence reads that were classified as Henipavirus spp. However, the sequences shared low nucleotide and amino acid identities with known henipaviruses.
 
Last edited:
Status
Not open for further replies.

ISF - Join now!

Every member here is approved by hand. No bots, no spam, just people who care about evidence and honest debate.

Membership is free!

Create your free account

Back
Top Bottom